GenMark Diagnostics Current Ratio 2010-2019 | GNMK

GenMark Diagnostics current ratio from 2010 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
GenMark Diagnostics Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $0.06B $0.02B 3.39
2019-03-31 $0.07B $0.02B 3.93
2018-12-31 $0.07B $0.02B 3.37
2018-09-30 $0.07B $0.02B 3.75
2018-06-30 $0.07B $0.04B 2.04
2018-03-31 $0.09B $0.03B 2.79
2017-12-31 $0.10B $0.03B 3.45
2017-09-30 $0.10B $0.04B 2.97
2017-06-30 $0.12B $0.03B 3.60
2017-03-31 $0.04B $0.02B 2.00
2016-12-31 $0.06B $0.03B 2.21
2016-09-30 $0.07B $0.02B 3.26
2016-06-30 $0.05B $0.02B 2.95
2016-03-31 $0.05B $0.01B 4.03
2015-12-31 $0.06B $0.01B 5.28
2015-09-30 $0.06B $0.01B 5.41
2015-06-30 $0.07B $0.01B 7.44
2015-03-31 $0.08B $0.01B 8.15
2014-12-31 $0.08B $0.01B 6.35
2014-09-30 $0.09B $0.01B 7.33
2014-06-30 $0.09B $0.01B 8.02
2014-03-31 $0.10B $0.01B 10.15
2013-12-31 $0.11B $0.01B 10.85
2013-09-30 $0.12B $0.01B 14.02
2013-06-30 $0.05B $0.01B 5.86
2013-03-31 $0.05B $0.01B 6.62
2012-12-31 $0.06B $0.01B 6.32
2012-09-30 $0.06B $0.01B 7.83
2012-06-30 $0.07B $0.01B 10.04
2012-03-31 $0.03B $0.01B 5.03
2011-12-31 $0.03B $0.01B 5.31
2011-09-30 $0.04B $0.01B 6.09
2011-06-30 $0.05B $0.01B 6.91
2011-03-31 $0.02B $0.00B 4.31
2010-12-31 $0.02B $0.00B 6.82
2010-09-30 $0.03B $0.00B 6.87
2010-06-30 $0.03B $0.00B 8.61
2010-03-31 $0.00B 0.00
2009-12-31 $0.00B 0.00
2009-09-30 $0.00B 0.00
2009-06-30 $0.00B 0.00
2009-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.345B $0.071B
GenMark Diagnostics, Inc. is a molecular diagnostics company focused on developing and commercializing its proprietary eSensor(R) detection technology. The eSensor? XT-8 system is the second generation in GenMark Dx's eSensor? platform, utilizing electrochemical detection technology to detect nucleic acids on a microarray. The XT-8 System enables multiplex detection of DNA and RNA targets. The Company has developed four diagnostic tests for use with its XT-8 System. Its Cystic Fibrosis Genotyping Test, which detects pre-conception risks of cystic fibrosis, and its Warfarin Sensitivity Test, which determines an individual's ability to metabolize the oral anticoagulant warfarin, have received FDA clearance. It has also developed a Respiratory Viral Panel Test, which detects the presence of major respiratory viruses, and a Thrombosis Risk Test, which detects an individual's increased risk of blood clots. GenMark Diagnostics, Inc. is based in Pasadena, California.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $118.240B 25.19
Intuitive Surgical (ISRG) United States $61.021B 53.37
Edwards Lifesciences (EW) United States $44.736B 43.54
IDEXX Laboratories (IDXX) United States $23.571B 59.13
Fresenius Medical Care AG KGaA (FMS) Germany $21.210B 14.24
Olympus (OCPNY) Japan $17.714B 133.03
Teleflex (TFX) United States $15.798B 33.53
SONOVA HOLDING (SONVY) Switzerland $14.350B 0.00
Sysmex ADR (SSMXY) Japan $14.145B 38.13
DexCom (DXCM) United States $14.133B 209.45
Hologic (HOLX) United States $13.365B 21.10
STERIS (STE) Ireland $12.346B 28.48
Varian Medical Systems (VAR) United States $10.559B 25.26
ABIOMED (ABMD) United States $8.727B 49.95
Masimo (MASI) United States $8.081B 49.03
SARTORIUS AG (SARTF) Germany $5.614B 49.88
Integra LifeSciences Holdings (IART) United States $5.208B 23.24
Penumbra (PEN) United States $5.143B 184.76
Globus Medical (GMED) United States $5.089B 32.30
Elekta AB (EKTAY) Sweden $5.065B 38.99
LivaNova (LIVN) United Kingdom $3.820B 29.13
Cantel Medical (CMD) United States $3.717B 37.71
Tandem Diabetes Care (TNDM) United States $3.610B 0.00
Nevro (NVRO) United States $2.758B 0.00
Wright Medical Group (WMGI) Netherlands $2.688B 235.78
Glaukos (GKOS) United States $2.645B 0.00
Integer Holdings (ITGR) United States $2.598B 18.38
Nihon Kohden (NHNKY) Japan $2.483B 24.98
AVANOS MEDICAL, INC (AVNS) United States $1.748B 32.42
Veracyte (VCYT) United States $1.262B 0.00
OPKO Health (OPK) United States $1.262B 0.00
Accelerate Diagnostics (AXDX) United States $1.160B 0.00
Silk Road Medical (SILK) United States $1.103B 0.00
CryoLife (CRY) United States $1.086B 103.39
Inogen (INGN) United States $1.077B 26.39
Natus Medical (NTUS) United States $1.060B 24.69
Luminex (LMNX) United States $0.999B 0.00
Mesa Laboratories (MLAB) United States $0.995B 45.99
ORTHOFIX MEDICAL INC (OFIX) United States $0.978B 30.71
Tactile Systems Technology (TCMD) United States $0.941B 116.21
Pacific Biosciences Of California (PACB) United States $0.864B 0.00
AngioDynamics (ANGO) United States $0.701B 22.82
OrthoPediatrics (KIDS) United States $0.578B 0.00
Intersect ENT (XENT) United States $0.572B 0.00
AxoGen (AXGN) United States $0.558B 0.00
Quotient (QTNT) Switzerland $0.535B 0.00
Si-Bone (SIBN) United States $0.488B 0.00
Fluidigm (FLDM) United States $0.403B 0.00
Oxford Immunotec Global (OXFD) United Kingdom $0.379B 14.56
Alphatec Holdings (ATEC) United States $0.352B 0.00
Sientra (SIEN) United States $0.344B 0.00
ViewRay (VRAY) United States $0.336B 0.00
Semler Scientific (SMLR) United States $0.290B 48.90
Accuray (ARAY) United States $0.257B 0.00
IRadimed (IRMD) United States $0.255B 42.40
SeaSpine Holdings (SPNE) United States $0.231B 0.00
RTI Surgical (RTIX) United States $0.229B 34.44
Neuronetics (STIM) United States $0.196B 0.00
ConforMIS (CFMS) United States $0.133B 0.00
EDAP TMS S.A (EDAP) France $0.129B 63.57
T2 Biosystems (TTOO) United States $0.128B 0.00
Second Sight Medical Products (EYES) United States $0.115B 0.00
Sensus Healthcare (SRTS) United States $0.101B 0.00
Apollo Endosurgery (APEN) United States $0.072B 0.00
Spectral Diagnostics (EDTXF) Canada $0.071B 0.00
Vermillion (VRML) United States $0.052B 0.00
Helius Medical Technologies (HSDT) United States $0.046B 0.00
Bioanalytical Systems (BASI) United States $0.040B 0.00
Ekso Bionics Holdings (EKSO) United States $0.039B 0.00
Neovasc (NVCN) Canada $0.031B 0.00
Restoration Robotics (HAIR) United States $0.026B 0.00
Nuvectra (NVTR) United States $0.026B 0.00
HTG Molecular Diagnostics (HTGM) United States $0.023B 0.00
ReWalk Robotics (RWLK) Israel $0.023B 0.00
Ra Medical Systems (RMED) United States $0.019B 0.00
DarioHealth (DRIO) Israel $0.016B 0.00
Lianluo Smart (LLIT) China $0.013B 0.00
OBALON THERPTCS (OBLN) United States $0.012B 0.00
Cesca Therapeutics (KOOL) United States $0.012B 0.00
Nanovibronix (NAOV) United States $0.011B 0.00
Dynatronics (DYNT) United States $0.010B 0.00
ENDRA Life Sciences (NDRA) United States $0.010B 0.00
Avinger (AVGR) United States $0.007B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Sunshine Heart Inc (CHFS) United States $0.005B 0.00
Allied Healthcare Products (AHPI) United States $0.005B 0.00
Viveve Medical (VIVE) United States $0.000B 0.00